SRDX: Surmodics, Inc. Company Profile & Statistics

About

Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings.

Info & Links

CEO

Gary R. Maharaj

Headquarters

9924 WEST 74TH STREET
EDEN PRAIRIE, MN 55344, UNITED STATES

Auditor

DELOITTE & TOUCHE LLP

Share holders

240

Employees

376

Surmodics, Inc. Statistics

Valuation Measures

Market Capitalization²

572.63M

Enterprise Value

577.84M

Enterprise Value/EBITDA(ttm)

374.74

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

4.55

Price to Book(mrq)

4.80

Price to Cash(ytd)

129.38

Profitability

Gross Margin(ttm)

73.75%

Operating Margin(ttm)

-3.63%

Profit Margin(ttm)

-9.27%

Return on Equity(ttm)

-3.79%

Return on Invested Capital(ttm)

-7.80%

Return on Assets(ttm)

-2.55%

Income Statement

Revenue(ttm)

120.82M

Revenue Per Share(ttm)

8.47

Gross Profit(ttm)

89.43M

EBITDA(ttm)³

1.54M

Net Income Available to Common(ttm)

-1.40M

Diluted EPS(ttm)

-0.81

Share Statistics

Beta (5Y Monthly)

1.22

52-Week Change

18.79%

S&P 500 52-Week Change

27.89%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

14.27M

Dividend Yield

0.00%

Float⁴

13.05M

% Held by Insiders

8.90%

% Held by Institutions

96.63%

Balance Sheet

Total Cash(mrq)

38.17M

Total Cash Per Share(mrq)

2.68

Total Debt(mrq)

29.52M

Total Debt/Equity(mrq)

24.86%

Current Ratio(mrq)

3.96%

Quick Ratio(mrq)

3.22%

Book Value Per Share(mrq)

8.30

Cash Flow

Operating Cash Flow Per Share(ytd)

0.02

Free Cash Flow(ytd)

-3.24M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

SRDX

Surmodics, Inc.

Surmodics, Inc. Profile